Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Cancer of prostate

Prostate cancer is one of the most commonly diagnosed cancer in males globally. It is a highly heterogeneous condition; it can be aggressive but will more typically develop

...


Read more on Cancer of prostate

 

 

Latest news articles

Added 1 month ago Drug news

PROSPER trial protocol of Xtandi (enzalutamide) in patients with non-metastatic castration-resistant prostate cancer is amended.- Astellas and Pfizer

Astellas Pharma Inc. and Pfizer Inc.announced the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind,...

Added 1 month ago Drug news

Phase III LATITUDE clinical trial shows Zytiga (abiraterone acetate) plus prednisone shows impressive improvement in survival in metastatic prostate cancer- Janssen R&D

Janssen Research & Development announced data from the pivotal phase III LATITUDE clinical trial, which showed Zytiga (abiraterone acetate) plus...

Added 2 months ago Drug news

Prolaris test accurately predicts the 10-year risk of metastases in men treated for prostate cancer.- Myriad Genetics Inc.

- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced new data demonstrating the utility of the...

Search all news articles for Cancer of prostate
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone


Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

Visit Prostate Cancer


Guidelines

EAU Guidelines on Prostate Cancer

The European Association of Urology (EAU) Guidelines Group for Prostate Cancer have prepared this guidelines document to assist medical professionals...

Added 1 year ago

Evidence-based indications for the use of PET-CT in the United Kingdom 2016

Since its introduction into clinical practice in the UK 26 years ago, positorn emission tomography (PET) followed by positron emission tomography-computed tomography...

Added 7 months ago

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 1 year ago

Search all guidelines for Cancer of prostate
 

Journal articles

Abiraterone for prostate cancer not previously treated with hormone therapy

Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer.

Added 5 days ago

Emotional distress increases the likelihood of undergoing surgery among men with localized prostate cancer

We determined whether among men with clinically localized prostate cancer, particularly men with low risk disease, greater emotional distress increases the likelihood of undergoing surgery vs radiation or active surveillance.

Added 1 month ago

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.

How best to treat rising prostate-specific antigen (PSA) concentration after radical prostatectomy is an urgent clinical question.

Added 1 month ago

Search all journal articles for Cancer of prostate
 

Clinical trials

Study of abiraterone acetate plus ADT versus apalatumide versus abiraterone and apalatumide in patients with advanced prostate cancer with non-castrate testosterone levels

Evaluation of the activity, safety and patients reported outcome of ADT plus abiraterone, abiraterone plus APALUTAMIDE (a second-generation antiandrogen) or APALUTAMIDE alone in hormone naïve locally advanced...

Added 9 months ago

Olaparib with or without cediranib in treating patients with metastatic hormone-resistant prostate cancer

This randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with hormone-resistant prostate cancer that has spread to other places in the body.

Added 9 months ago

Hormone therapy with or without definitive radiotherapy in metastatic prostate cancer

PART I - Hormone therapy with or without definitive radiotherapy in metastatic prostate cancer
The goal of this clinical study PART I is to determine impact of radiotherapy treatment in combination with...

Added 9 months ago

Search all clinical trials for Cancer of prostate
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

CME

Managing the side effects of treatment for prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Managing patients at risk of prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Guidance update: latest NICE guidelines on prostate cancer

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
154.8
Search all CME for Cancer of prostate